THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the safety and efficacy of lixivaptan in the treatment of hyponatremia in patients with congestive heart failure.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: CardioKine Inc.
• Collaborators: Biogen; Cardiokine Biopharma, LLC

Criteria

Inclusion Criteria:

• Male and female patients 18 years of age or older with hyponatremia and hospitalized for congestive heart failure.